,trastuzumab deruxtecan
Daiichi Sankyo,AstraZeneca
['breast']
we woke up today to the publication of the destiny breast 04 in the nejm. now we see the results again at the asco plenary! certainly practice changing! #asco2022 #asco22 
Breast cancer specialist. Shoe lover. Cupcake connoisseuse. Opinions are my own, RTs not an endorsement.